Predictors of HIV-related Risk Perception and PrEP Acceptability Among Young Adult Female Family Planning Patients
Overview
Authors
Affiliations
HIV pre-exposure prophylaxis (PrEP) presents new opportunities for HIV prevention. While women comprise approximately 20% of new HIV infections in the US, significant questions remain about how to most effectively facilitate PrEP uptake for this population. Family planning clinics are a dominant source of health care for young women and support an estimated 4.5 million women annually. We explore characteristics associated with HIV risk perception and PrEP acceptability among young adult women seeking reproductive health services in a high-prevalence setting. A cross-sectional, clinic-based survey was conducted with women ages 18-35 (n = 146) seeking health care at two family planning clinics in the greater Baltimore, Maryland area, from January to April 2014. An estimated 22% of women reported being worried about HIV risk, and 60% reported they would consider taking a pill daily to prevent HIV. In adjusted models, HIV-related worry was associated with having no college education, being single or dating more than one person, practicing consistent condom use during vaginal sex, and having ever traded sex. PrEP acceptability was significantly associated with being Black (71% vs. 49%, AOR 2.23, CI: 1.89-2.64) and having ever traded sex (83% vs. 58%, AOR 4.94, CI: 2.00-12.22). For women with a history of intimate partner violence (IPV), PrEP acceptability was significantly lower (57% vs. 62%, AOR .71, CI: .59-.85) relative to their non-abused counterparts. Results suggest that family planning clinics may be a natural setting for PrEP discussion and roll-out. They should be considered in the context of integrating HIV prevention with reproductive health services. Women with a trauma history may need additional support for implementing HIV prevention in the form of PrEP.
Johnson A, Ott E, Friedman E, Pandiani A, Moore A, Alvarez I BMJ Public Health. 2025; 3(1):e000809.
PMID: 40017987 PMC: 11812854. DOI: 10.1136/bmjph-2023-000809.
Facilitators and barriers of HIV pre-exposure prophylaxis use among four key populations in Iran.
Moameri H, Shahrbabaki P, Tavakoli F, Saberi P, Mirzazadeh A, Goudarzi R BMC Health Serv Res. 2024; 24(1):1433.
PMID: 39563358 PMC: 11575091. DOI: 10.1186/s12913-024-11933-w.
Sims Haynes A, Markham C, Schick V, Suchting R, Parthasarathy N, Choudhury S AIDS Behav. 2024; 29(1):101-132.
PMID: 39340583 PMC: 11739211. DOI: 10.1007/s10461-024-04491-z.
Sheth A, Diallo D, Ellison C, Er D, Ntukogu A, Komro K JMIR Res Protoc. 2024; 13:e56293.
PMID: 38517456 PMC: 10998174. DOI: 10.2196/56293.
Clement M, Perry B, McKenna K, Beckford J, Davenport T, Murray E AIDS Patient Care STDS. 2024; 38(3):144-150.
PMID: 38471093 PMC: 10956506. DOI: 10.1089/apc.2023.0300.